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 I 
ABSTRACT  
 
Introduction: Autoimmune diseases are caused by the loss of immunologic 
tolerance to self-antigens, causing the formation of autoantibodies, which mistakenly 
attack the body. Allergic diseases are also common causes of chronic illnesses 
contributing to rising health costs. Actually, the term “allergy” is frequently used 
synonymously with IgE-mediated allergic disease. Some authors considered that these 
diseases are at opposite sides of the spectrum of the immune response because 
autoimmune and allergic diseases are considered T helper 1- and T helper 2-mediated 
diseases, respectively. However, despite these diseases have different clinical 
manifestations, there has been an increasing evidence of association between them. 
Objectives: The proposed study aimed at systematically review the link between 
autoimmune and allergic diseases: to investigate the etiology, pathophysiology and risk 
factors in order to clarify the relationship among the two groups.  
Development: This work was carried out by searching data on Pubmed using the 
keywords "autoimmune diseases”, “autoimmunity”, "allergic", “allergy”, “atopy”. Some 
authors reported a link between allergic rhinitis, asthma and systemic lupus erythematous 
as well as a relationship between autoimmune thyroid diseases and additional 
autoimmune/allergic diseases. In fact, both allergic and autoimmune diseases are 
manifestations of immunological hypersensitivity that arise when controlling mechanisms 
to innocuous environmental or endogenous antigens break down. Although there is an 
increasing evidence of a relationship between some allergic and autoimmune diseases, 
there is a lack of information in what concerns the pathophysiological mechanisms that 
explain it. 
Conclusions: Based on the findings of this review, given the increasing evidence 
of a relationship between autoimmune and allergic diseases and the lack of knowledge in 
what concerns the overlap of their pathophysiologic mechanisms, future research should 
focus on identifying the basic mechanism of this relationship.  
 
KEYWORDS: autoimmune diseases; autoimmunity; allergic; allergy; atopy 
 II 
RESUMO  
 
 Introdução: As doenças autoimunes são causadas pela perda de tolerância 
imunológica aos autoantigénios, levando à formação de autoanticorpos, que atacam o 
organismo por engano. As doenças alérgicas também são uma causa comum de 
doenças crónicas contribuindo para o aumento dos custos em saúde. Na verdade, o 
termo "alergia" é frequentemente utilizado como sinónimo de doença alérgica medidada 
por IgE. Alguns autores consideraram que estas doenças estão em lados opostos do 
espectro da resposta imunológica, porque as doenças autoimunes e alérgicas são 
consideradas doenças mediadas por células Th1 e Th2, respetivamente. No entanto, 
apesar destas doenças terem manifestações clínicas diferentes, tem havido uma 
evidência crescente da associação entre elas. 
 Objetivos: O estudo proposto pretendeu rever sistematicamente a relação entre 
doenças autoimunes e alérgicas: investigar a etiologia, fisiopatologia e fatores de risco 
para esclarecer a relação entre os dois grupos. 
 Desenvolvimento: Este trabalho foi realizado através da pesquisa de dados no 
Pubmed usando as palavras-chave "doenças autoimunes", "autoimunidade", "alérgica", 
"alergia", "atopia". Alguns autores descreveram uma ligação entre rinite alérgica, asma e 
lúpus eritematoso sistémico, assim como uma relação entre doenças autoimunes da 
tiróide e doenças autoimunes/alérgicas adicionais. De facto, tanto as doenças alérgicas 
como as autoimunes são manifestações de hipersensibilidade imunológica que surgem 
quando há uma desregulação dos mecanismos de controlo de antigénios ambientais ou 
endógenos. Apesar de haver uma evidência crescente da relação entre algumas doenças 
alérgicas e as doenças autoimunes, existe ainda falta de informação no que diz respeito 
aos mecanismos fisiopatológicos que a explicam. 
 Conclusões: Com base nos resultados desta revisão, dado a crescente 
evidência de uma relação entre doenças autoimunes e alérgicas e a falta de 
conhecimento sobre a sobreposição de seus mecanismos fisiopatológicos, no futuro, a 
investigação deverá concentrar-se na identificação do mecanismo básico dessa relação. 
 
PALAVRAS-CHAVE: doenças autoimunes; autoimunidade; alérgicas; alergia; atopia 
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PGM – phosphoglucomutase 
SHVEM – soluble herpes virus entry mediator 
SoJIA – systemic onset juvenile idiopathic arthritis 
TGF – tumour growth factor 
Th – T helper 
TNFR - tumour necrosis factor receptor 
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 1 
INTRODUCTION 
 
Atopic and autoimmune reactions belong to the group of hypersensitivity reactions 
of the immune system. They are categorized in different names depending on whether the 
antigen triggering the reaction is endogenous or exogenous, types of cellular and humoral 
components involved, and clinical symptoms (Andersen et al., 2017).  
Autoimmune diseases (AID) are characterized by the reaction of cells (auto 
reactive T-lymphocytes) or products (autoantibodies) of the immune system against the 
organism’s own antigens (autoantigens). It may be part of the physiological immune 
response (natural autoimmunity) or pathologically induced, which may eventually lead to 
the development of clinical abnormalities – AID. The incidence of AID has increased in 
recent decades (D'Angelo et al., 2016) and their chronic and debilitating characteristics 
have become a massive burden on patients, families and society, with high medical costs 
and reduced quality of life (Zhang et al., 2016).  
The AID are classified based on site of involvement and nature of lesion as 
hemocitolytic, localized (or organ specific) and systemic (or non-organ specific) 
(McGonagle et al., 2006). Despite the classification, all AID’s subtypes usually exhibit an 
elevated level of immunoglobulins, demonstrable autoantibodies, accumulation of 
lymphocytes and plasma cells at the sites of lesion, benefit with corticosteroid or other 
immunosuppressive therapy, the occurrence of more than one type of autoimmune lesion 
in an individual, a genetic predisposition toward autoimmunity, higher incidence among 
females and chronicity (usually nonreversible) (Kasper et al., 2015).  
Although these conditions have a multifactorial pathogenesis, the generally 
accepted model is that immune dysregulation, secondary to an infectious process or 
excessive exposure to an inciting or cross-reactive antigen, promotes a T helper (Th)1 
response leading to progressive inflammation and autoimmunity (D'Angelo et al., 2016). 
These diseases may result from multiple interactions of genes and environmental factors. 
In fact, even if inherit a genetic predisposition, the AID will not occur unless there is an 
environmental trigger. In what concerns the genetic factors in autoimmunity, different 
genes can increase susceptibility to autoimmune diseases including genes encoding 
histocompatibility molecules, complement proteins, immunoglobulins, peptide transporter 
proteins, and genes controlling the production of sex hormones. On the other hand, there 
are also several suspects in the search for triggers such as viruses, bacteria, diet, toxins, 
radiation, metal, estrogen and chronic infections. Thus, in an individual with a susceptible 
genotype, exposure to environmental factors can act to initiate an autoimmune process 
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(Carson, 1992).  
Similarly to AID, allergic diseases are very common in developed countries, 
particularly among children, adolescents and young adults (Żukiewicz-Sobczak et al., 
2012). Allergic rhinitis, asthma, and atopic eczema are among the commonest causes of 
chronic diseases contributing to rising health costs (Kay, 2001). Although the term 
“allergy” has been introduced in 1906 by von Pirquet, who recognized that in both 
protective and hypersensitivity reactions, antigens had induced changes in reactivity, the 
term was corrupted and now is frequently used synonymously with immunoglobulin (Ig) E-
mediated allergic disease (Kay, 2001). Thus, atopy is a genetic predisposing factor to 
produce IgE antibodies in response to low doses of allergens and to develop typical 
symptoms such as atopic dermatitis, allergic rhinitis and asthma (Johansson et al., 2001; 
Miraglia Del Giudice et al., 2012). Atopic diseases have increased in frequency in recent 
decades and now affect approximately 20% of the population worldwide (Spergel, 2010). 
The risk of developing atopic diseases is complex and is strongly influenced by 
environmental and genetic factors (Bantz et al., 2014; Spergel, 2010), playing the latter 
the main role. In what concerns the environmental factors, it was been described factors 
as infectious agents (human rhinoviruses, respiratory syncytial virus, and mycoplasma), 
allergens (house dust mites, pollens, pets, and molds), pollutants and medication 
exposure (Asher et al., 2010; Guilbert et al., 2010; Nishimura et al., 2013). 
Allergic diseases are due to an immunological response to a usually innocuous 
antigen (allergen) resulting in the proliferation of Th2 lymphocytes (Pacheco-Gonzalez et 
al., 2016). 
Some authors considered that these diseases are at opposite sides of the 
spectrum of the immune response. In fact, as mentioned, AID, such as multiple sclerosis, 
rheumatoid arthritis and type 1 insulin-dependent diabetes mellitus, are considered Th1-
mediated diseases, while allergic disorders, such as asthma, food allergy or rhinitis, are 
considered to be Th2-mediated diseases (Pedotti et al., 2003). However, despite these 
diseases have different clinical manifestations, there has been an increasing evidence of 
association between allergic conditions and AID in the last years (Larche et al., 2005). As 
an example, some authors reported a link between several allergic disorders such as 
allergic rhinitis or asthma and systemic lupus erythematous (Morton et al., 1998; 
Sekigawa et al., 2003; Sin et al., 2016). In fact, both allergic and AID are manifestations of 
immunological hypersensitivity that arise when mechanisms controlling responses to 
innocuous environmental antigens (such as allergens) or to endogenous host ('self') 
proteins, break down (Dagdelen et al., 2012). The reason of certain individuals suffer from 
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particular hypersensitivities is unclear, however there is evidence that both genetic and 
environmental factors influence their susceptibility (Larche et al., 2005). 
Although there is an increasing evidence of a relationship between some allergic 
and AID, there is a lack of a systematic review that identify the most prevalent 
associations as well as the current pathophysiological mechanisms that explain it. Thus, 
the authors decide to make a literature review that summarizes what was studied in last 
fifteen years regarding the connection between atopy and AID. The proposed study aims 
to systematically review the link between autoimmune and allergic diseases: to investigate 
the etiology, pathophysiology and risk factors of allergic and AID in order to clarify the 
relationship between the two groups.  
 
  
 4 
METHODS 
 
Search strategy 
We conducted a systematic review about the link between autoimmune and 
allergic diseases. The search was conducted on March 7, 2017 using PubMed database 
with the keywords “autoimmune diseases” or “autoimmunity” in conjunction (or not) with 
“allergic”, “allergy” or “atopy”. The search was restricted to original paper researches 
published in the last fifteen years (after January 1, 2002) in the english language. The 
results of search included a total of 38 992 articles. 
 
Article selection  
All titles were screened for keywords related to autoimmune and allergic diseases. 
All review were removed, reminding 30 086 papers. The papers tittles were analyzed and, 
after non-related and duplicates removal, remained 57 articles selected. In the next step, 
all abstracts were reviewed by one author (Certal M) and a final decision on their inclusion 
in or exclusion from this review was made based on the following criteria: (1) being an 
original paper research (reviews were excluded); (2) published in the english language; 
(3) published after January 1, 2002 and before March 7, 2017; (4) includes a correlation 
between autoimmune and allergic diseases in the title. Of 57 full text screened, 28 
publications were included in this review.   
Introduction, discussion and review papers provided background to our systematic 
review but were not included in the data extraction form, as they did not provide primary 
data.  
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DEVELOPMENT 
 
The link between autoimmune and allergic diseases 
The widely-debated link between allergic diseases and autoimmunity aims to 
establish, in the most recent studies, if the autoreactivity can represent a simple 
epiphenomenon of the chronic inflammation or whether it is the key element in the 
development of allergic diseases or whether allergic diseases are associated with the 
development of autoimmunity. 
Despite the relationship between autoimmune and allergic diseases remain 
controversial, in the past fifteen years, more groups reported a link between them. This 
link exists in respect to the epidemiology, etiology, risk factors, as well as, 
pathophysiology. 
 
Epidemiology 
In what concerns the study of epidemiologic parameters, such as incidence and 
prevalence of allergic and AID, some epidemiological studies suggested a lower incidence 
of allergy among patients with AID, including rheumatoid arthritis (Rudwaleit et al., 2002; 
Verhoef et al., 1998) and multiple sclerosis (Bergamaschi et al., 2009). These data were 
supported by the counteracting immune mechanisms of these diseases. In fact, as 
described above, AID are considered Th1/Th17-mediated diseases, while allergic 
disorders are considered to be Th2-mediated diseases (Pedotti et al., 2003) and these 
mechanisms may be responsible for the differences in the prevalence of them. However, 
more recently, despite the different immune mechanisms and clinical manifestations of 
allergic and AID, there has been an increasing evidence of association between them 
(table 1) (Kreiner et al., 2017; Larche et al., 2005; Rabin et al., 2008). 
Concerning allergic and AID epidemiology data uncovered in the last fifteen years, 
Dagdelen and collaborators described that patients with autoimmune thyroid diseases 
(particularly, Hashimoto’s thyroiditis and Graves’ disease) were prone to additional 
autoimmune/allergic diseases (Dagdelen et al., 2012). The distribution of these disorders 
were 10.2% gastrointestinal (chronic atrophic gastritis, celiac disease, autoimmune 
pancreatitis, ulcerative colitis, primary biliary cirrhosis), 6.6% allergic (asthma, chronic 
urticaria, rhinosinusitis), 4.4% rheumatological (rheumatoid arthritis, systemic lupus 
erythematosus, Still disease, Sjögren syndrome, Behçet’s disease, ankilosying 
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spondylitis), 3.7% skin (vitiligo, psoriasis, idiopathic pruritus, total alopecia), 1.5% 
endocrinological (hypoparathyroidism, type-1 diabetes mellitus, hypophysitis), 0.4% 
hematological (idiopathic thrombocytopenic purpura), 0.4% renal (crescenteric 
glomerulonephritis) involvements in Hashimoto’s thyroiditis. In Graves’ disease, these 
distributions were similar with 3.8% gastrointestinal, 3.8% allergic, 3.8% skin, 1.9% 
rheumatological and 1.9% hematological. In this work, the mostly involved organ system 
described was the gastrointestinal tract in both, that, probably, takes play in exaggeration 
of some symptoms by leading to anemia caused by both vitamin B12 and iron 
deficiencies, especially in patients with Hashimoto’s thyroiditis (Dagdelen et al., 2012).  
Barahmani and collaborators performed a previous study, using National AA 
Registry database, with the purpose of investigate the association between history of 
atopy (asthma, atopic dermatitis, and hay fever) or AID (irritable bowel syndrome, 
psoriasis, and any thyroid disorder) and risk of alopecia areata. The results revealed that 
processing a history of any atopic or autoimmune disease was associated with an 
increased risk of alopecia areata. There was no trend for possessing a history of more 
than one atopic or autoimmune and increasing risk of alopecia areata. This analysis 
revealed that a history of atopy and autoimmune disease was associated with an 
increased risk of alopecia areata and that the results were consistent for both the severe 
subtype of alopecia areata (ie, alopecia totalis and alopecia universalis) and the localized 
subtype (ie, alopecia areata persistent) (Barahmani et al., 2009). 
A population-based case-control study investigated the association between 
common allergic diseases (allergic conjunctivitis, allergic rhinitis, atopic dermatitis, 
asthma, and urticaria) and the subsequent risk of developing primary immune 
thrombocytopenia during childhood (Chiang et al., 2015). In these work, Chiang and 
collaborators showed that children with every type of allergic disease examined (except 
asthma) exhibited an increased risk of developing primary immune thrombocytopenia. In 
addition, in the last year, some authors conducted a population-based cohort analysis and 
described a significantly increased incidence of primary immune thrombocytopenia in 
children with atopic dermatitis and showed that children with both atopic dermatitis and 
primary immune thrombocytopenia had higher occurrence rates of other autoimmune 
diseases (Wei et al., 2016).  
It has been also described a significant association between common allergic 
diseases, such as asthma and allergic rhinitis, and the incidence of rheumatoid arthritis in 
a population-based cohort study (Lai et al., 2015). In addition, this study also 
demonstrated that patients with more than one allergic disease had an increased risk of 
developing rheumatoid arthritis (Lai et al., 2015). 
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Recently, Andersen and collaborators also suggested that atopic dermatitis was 
significantly associated with alopecia areata, vitiligo, chronic urticaria, celiac disease, 
chronic glomerulonephritis, Sjögren syndrome, systemic lupus erythematous, ankylosing 
spondylitis, Crohn’s disease, unspecified inflammatory bowel disease (patients with 
concurrent diagnosis of Crohn’s disease and ulcerative colitis), ulcerative colitis and 
rheumatoid arthritis. In this study, atopic dermatitis was also associated with having 
multiple autoimmune comorbidities and patients with history of smoking had a significantly 
higher occurrence of them compared to nonsmokers (Andersen et al., 2017).  
Lin and collaborators, in 2016, described, in a population-based case-control 
study, that children with onset of allergic diseases were at increased risk of developing 
juvenile idiopathic arthritis and the increased risk was associated with the cumulative 
effect of concurrent allergic diseases and frequency of seeking medical care (Lin et al., 
2016). 
Another group documented a twofold prevalence of chronic autoimmune thyroiditis 
in systemic nickel allergic syndrome subjects compared that observed in patients with no-
systemic nickel allergic syndrome immune diseases (26.5 vs 12.7 %, p < 0.01) (Andrioli et 
al., 2015). In what concerns the nickel-induced allergy, more studies were performed in 
order to identify a link between AID’s development. Al-Mogairen and collaborators 
performed an experimental study in Brown Noeway rats that aimed at investigate whether 
nickels chloride can induce autoimmunity and cutaneous sclerosis in immunosensitive 
rats. In this work, serum ANA was high in a significant number of rats in both the oral and 
subcutaneously nickel-treated groups, while the anti-SCL70 was high in a significant 
number of rats in only the orally nickel-treated group. Histologically, subcutaneous and 
oral nickel-treated groups showed sclerodermic features of the skin, respectively. This 
study suggested that nickel chloride can induce scleroderma-related autoantibodies and 
cutaneous sclerosis, and a more prolonged duration of exposure is probably associated 
with greater risk (Al-Mogairen et al., 2010).   
Yeh and collaborators performed a national population-based study and described 
an increased subsequent risk of myasthenia gravis in patients with allergic conjunctivitis, 
allergic rhinitis, Hashimoto thyroiditis, and Graves’ disease, suggesting an association 
between allergic or AID and the risk of myasthenia gravis. In addition, they also described 
that the highest risk of subsequent myasthenia gravis was associated with combined 
allergic conjunctivitis and Hashimoto thyroiditis (Yeh et al., 2015). 
Finally, although some studies not clearly evidence the link between autoimmune 
and allergic diseases, they show that these diseases tend to walk side by side. For 
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example, it was described, in a population-based study, an association between attention 
deficit hyperactivity disorder and allergic/autoimmune diseases, particularly, asthma, 
allergic rhinitis, atopic dermatitis, urticaria, ankylosing spondylitis, ulcerative colitis and 
autoimmune thyroid disease (Chen et al., 2017).  
Despite the increasing epidemiologic evidence of a link between autoimmune and 
allergic diseases, there also have been reported no differences between them. For 
example, a study performed in adult and pediatric alopecia areata patients demonstrated 
that the frequencies of autoimmune and atopic diseases were not different between these 
groups and control group. In addition, they also showed no statistically significance 
between disease severity and personal or familiar history of AID in the two groups 
(Serarslan et al., 2012). Another study performed by Alonso and collaborators show 
controversy results. This group conducted a case-control study in order to assess the 
association between history of allergy (pollens, house dust, animal dander, foods, drugs 
allergy and clinical manifestations such as conjunctivitis, rhinitis, asthma or hives) and 
autoimmune diseases (such as multiple sclerosis, optic neuritis, systemic lupus 
erythematous, rheumatoid arthritis, hyperthyroidism, and type 1 diabetes), and the risk of 
multiple sclerosis. In this work, history of allergy was not associated with multiple sclerosis 
risk and a modest association was found between family history of other AID and multiple 
sclerosis. Thus, family history of other autoimmune diseases was associated with a higher 
multiple sclerosis risk, suggesting a common genetic background or shared environmental 
triggers. There was no clear association between personal history of allergy and risk of 
multiple sclerosis (Alonso et al., 2008). 
 
Table 2 Epidemiological evidence of association between autoimmune and allergic 
diseases. 
AUTOIMMUNE DISEASE ALLERGIC DISEASE 
Alopecia areata (Andersen et al., 2017) 
• Atopic dermatitis (Andersen et al., 
2017; Barahmani et al., 2009) 
• Asthma (Barahmani et al., 2009) 
• Hay fever (Barahmani et al., 2009) 
Ankylosing spondylitis (Andersen et 
al., 2017) 
• Atopic dermatitis (Andersen et al., 
2017) 
Autoimmune thyroiditis (Andrioli et al., 
2015; Dagdelen et al., 2012) 
• Asthma (Dagdelen et al., 2012) 
• Chronic urticaria (Dagdelen et al., 
2012)  
• Rhinosinusitis (Dagdelen et al., 2012) 
• Systemic nickel allergic syndrome 
(Andrioli et al., 2015) 
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Finally, some studies appeared that aimed at study not the relation between the 
AID and the allergic diseases but, rather, the relationship between the applied treatments 
and the further development of these diseases. Accordingly, Bozek and collaborators 
performed a 20-year observational evaluation post-specific immunotherapy, a therapy that 
involves the stimulation of immune tolerance with regard to a particular allergen and that 
is a recognized treatment for selected allergic diseases, such as allergic rhinitis and 
conjunctivitis, food allergies or atopic dermatitis (Pitsios et al., 2015). This work was 
Celiac disease (Andersen et al., 2017) • Atopic dermatitis (Andersen et al., 
2017) 
Crohn’s disease (Andersen et al., 2017) • Atopic dermatitis (Andersen et al., 
2017) 
Chronic glomerulonephritis (Andersen 
et al., 2017) 
• Atopic dermatitis (Andersen et al., 
2017) 
Chronic urticaria (Andersen et al., 2017) • Atopic dermatitis (Andersen et al., 
2017) 
Graves’ disease (Dagdelen et al., 2012) 
• Asthma (Dagdelen et al., 2012) 
• Chronic urticaria (Dagdelen et al., 
2012)  
• Rhinosinusitis (Dagdelen et al., 2012) 
Juvenile idiophatic arthritis (Lin et al., 
2016) • Allergic diseases (Lin et al., 2016) 
Myasthenia gravis (Yeh et al., 2015)  • Allergic conjunctivitis (Yeh et al., 2015) 
• Allergic rhinitis (Yeh et al., 2015) 
Primary immune thrombocytopenia 
(Chiang et al., 2015; Wei et al., 2016) 
• Allergic conjunctivitis (Chiang et al., 
2015) 
• Allergic rhinitis (Chiang et al., 2015) 
• Atopic dermatitis (Chiang et al., 2015; 
Wei et al., 2016) 
• Asthma (Chiang et al., 2015) 
• Urticaria (Chiang et al., 2015) 
Reumathoid arthritis (Andersen et al., 
2017; Lai et al., 2015) 
 
• Atopic dermatitis (Andersen et al., 
2017) 
• Asthma (Lai et al., 2015)  
• Allergic rhinitis (Lai et al., 2015) 
Sjögren syndrome (Andersen et al., 
2017) 
• Atopic dermatitis (Andersen et al., 
2017) 
Systemic lupus erythematous 
(Andersen et al., 2017) 
• Atopic dermatitis (Andersen et al., 
2017) 
Scleroderma (Al-Mogairen et al., 2010) • Systemic nickel allergic syndrome (Al-
Mogairen et al., 2010) 
Vitiligo  (Andersen et al., 2017) • Atopic dermatitis (Andersen et al., 
2017) 
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performed for an assessment of any manifestations of AID or the appearance of 
autoantibodies in serum of post-specific immunotherapy patients (Bozek et al., 2015). 
Unlike the other studies, in this work, they didn´t find no significant differences in the AID 
prevalence between the allergic patients with or without post-specific immunotherapy. 
However, significantly higher prevalence of 4 different autoimmune diseases were 
observed in the non-allergic patients during the same period. Additionally, the incidence of 
8 different autoantibodies was significantly higher in non-allergic patients than in control 
subjects. Hashimoto’s disease was the most common AID observed. The results of this 
long-term observational study indicated a lack of a significant prevalence of new instances 
of AID during 20 years of observation post-specific immunotherapy and at a rate lower 
than that of non-allergic control subjects, suggesting that specific immunotherapy is safe 
in this regard in the long term (Bozek et al., 2015). 
 
Etiology 
Despite the increasing evidence of a relationship between some allergic and AID, 
particularly in what concerns the epidemiological data, there is a lack of information about 
the etiology of both diseases as well as the pathophysiological mechanisms that explain it.  
Genetic and environmental factors participate in the pathogenic mechanisms of 
both autoimmune and allergic diseases (Pacheco-Gonzalez et al., 2016). This observation 
is in apparent contrast with the understanding of allergy and AID as representatives of 
distinct immunological disorders with counteracting underlying immune mechanisms 
(Kreiner et al., 2017). 
In what concerns genetic factors or heredity of autoimmune and allergic diseases, 
it was documented that the occurrence of some autoimmune disorders in parents, 
especially psoriasis and rheumatoid arthritis/ankylosing spondylitis, significantly increases 
the occurrence of allergic diseases in their children (Maas et al., 2014). 
In fact, genetic factors also have been described as major etiologic factors of 
autoimmune and allergic diseases, participating in the pathogenic mechanisms of both. 
Both allergy and AID are highly heritable diseases and an increasing number of 
susceptibility loci have been discovered. Some studies demonstrated substantial 
commonalities between them in terms of susceptibility loci, genetic pathways and genomic 
regulatory sites.  
Kreiner and collaborators performed a meta-analysis and described an enrichment 
of allergy associated loci in 29 among 290 loci previously associated with 16 autoimmune 
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diseases (Kreiner et al., 2017). Despite some limitations of the study, such as the different 
clinical phenotypes, with allergic sensitization often being present without symptoms and 
vice versa, this overlap in genetic mechanisms seemed to be a general phenomenon for 
allergy or AID, and distinct from other diseases (Kreiner et al., 2017).  
Recently, Pacheco-Gonzalez and collaborators also demonstrated, through an 
observational case-control study, that there are some genetic variants of Forkhead Box 
P3 (FOXP3), a gene involved in IPEX syndrome (immunodysregulation 
polyendocrinopathy enteropathy X-linked), also called XLAAD or X-linked autoimmunity-
allergic dysregulation (Chatila et al., 2000), that are significantly more frequent in children 
who share allergic and AID (Pacheco-Gonzalez et al., 2016). In this work, the authors 
defined 13 different polymorphisms in the FOXP3 gene, seven of which had not been 
previously described. There was an increase in the presence of the mutated allele in the 
position 7340C>T, specifically in those patients that suffered from both atopic and 
autoimmune diseases. This polymorphism is located in the 3’ untranslated region, which is 
described as regulatory region, since it could modify mRNA stability and translation 
efficiency (Bennett et al., 2001). In addition, this polymorphism could modify cellular 
localization signals affecting protein location, and consequently, FOXP3 function.  
Studying commonalities in the genetic characteristics of both autoimmune and 
allergic diseases could provide a key to understand the complex relationship between 
them by pinpointing possible common pathophysiological mechanisms. In fact, this might 
help to explain the mechanisms and aetiologies responsible for the contemporaneous, 
dramatic increase in incidence of allergic and AID (Bach, 2002; Kreiner et al., 2017). 
Despite the importance of genetic factors in these diseases appearance, 
environmental factors also contribute to the development of both autoimmune and allergic 
diseases. However, although it is well documented that both autoimmune and allergic 
diseases are influenced by environmental factors, there are few studies published in the 
last fifteen years that demonstrate a clear association between them. In fact, recently, only 
a cohort study performed by Sevelsted and collaborators, demonstrated that allergy and 
autoimmune disorders share environmental risk factors including birth by caesarean 
section (Sevelsted et al., 2015). In this study, the authors demonstrated that children 
delivered by caesarean had significantly increased risk of asthma, systemic connective 
tissue disorders, juvenile arthritis, inflammatory bowel disease, immune deficiencies, and 
leukaemia (Sevelsted et al., 2015). 
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Pathophysiology  
Atopy and autoimmunity are two potential outcomes of dysregulated immunity 
(D'Angelo et al., 2016; Shah, 2012). As mentioned above, AID are in general thought to 
act through a Th1-driven cell mediated immune response, while allergy and asthma 
involve a Th2-mediated response (Kreiner et al., 2017). Type 1 responses, directed by 
Th1 CD4+ T cells and identified by signature cytokine interferon (IFN)-ɣ, are considered as 
protective against infections by intracellular pathogens (O'Garra et al., 2004) and have 
been implicated in the pathogenesis of AID, such as thyroid disease, rheumatoid arthritis, 
juvenile rheumatoid arthritis, insulin-dependent diabetes mellitus and multiple sclerosis 
(Romagnani, 1991). By contrast, type 2 responses, directed by Th2 CD4+ T cells and 
identified by the signature cytokines interleukin (IL)-4, IL-5 and IL-13, are considered to 
play a pathogenic role in allergic diseases (Robinson, 2004). However, some observations 
have identified additional lymphocyte subsets, such as Th17 cells (Wynn, 2005), soluble 
factors such as IL-9 (Nowak et al., 2010) and regulatory T cells (Bacchetta et al., 2007) as 
a common link between atopy and autoimmunity. In fact, despite the reciprocal counter-
regulation of Th1 and Th2 cells (Sornasse et al., 1996) predicts that Th1-type AID and 
Th2-mediated allergic diseases would occur in mutually exclusive populations of patients, 
recent observations have challenged the validity of the long-standing Th1/Th2 paradigm 
(Steinman, 2007) and explain the immunological basis of cellular immune-mediated host 
defense and the pathogenesis of autoimmune and allergic diseases through a more 
complex hypothesis. As mentioned above, there is an increasing in the co-prevalence of 
autoimmune and allergic diseases. In addition, it also has been reported that infantile 
atopy increases a predisposition to autoimmune disorders, suggesting that these two 
entities might have common immune pathways, and justifying partially the increased co-
prevalence of atopic and autoimmune diseases (Kokkonen et al., 2004; Rabin et al., 
2008).  
In what concerns the investigation of the pathophysiology of autoimmune and 
allergic diseases in the last five years, there is a lack of information and investigation. 
However, some papers give clues to the underlying pathophysiological mechanisms. In 
the study performed by Pedullá and collaborators, in addition to the increased prevalence 
of thyroid autoimmunity in children with atopic dermatitis, they also demonstrated that the 
frequency of thyroid autoimmunity was significantly higher among children with IgE-
mediated than non-IgE-mediated atopic dermatitis, suggesting atopy and thyroid 
autoimmunity as potential outcomes of dysregulated immunity (Pedulla et al., 2014). In 
line with this, Liphaus and collaborators demonstrated that juvenile systemic lupus 
erythematosus patients have increased IgE serum levels, an increase that was not related 
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to allergic or parasitic diseases. These results are in line with the hypothesis that high IgE 
levels can be considered a marker of immune dysregulation (Liphaus et al., 2012). 
In 2012, Lau and collaborators demonstrated that genetic deletion of STAT6, the 
key transcription factor for development of Th2 immunity, in lupus-prone Lyn-deficient 
mice, results in a profound skewing towards autoimmunity (classically described as a Th1-
mediated immune response). In this work, they also demonstrated that STAT6 deficiency 
on a Lyn-deficient mice background suppresses spontaneous Th2 immunity in young mice 
but leads to early onset autoimmune disease and atopy in older mice (Lau et al., 2012). It 
is of note that current therapies in the treatment of asthma are designed to target the Th2 
pathway via inhibition of IL-4/13 or STAT6 signalling. On the discussion, the authors 
suggested that these types of strategies should now be viewed with caution, as they could 
lead to severe unwanted autoimmune responses or atopy in intrinsically susceptible 
individuals (Lau et al., 2012). 
Chai and collaborators performed a study to examine the production capacity of IL-
10 and transforming growth factor β (TGF-β) 2 regulatory cytokines, in individuals with 
concomitant allergic rhinitis and Th1-type autoimmune diagnoses (type 1 diabetes 
mellitus, rheumatoid arthritis, Crohn disease, multiple sclerosis, thyroiditis (excluding 
Graves’ disease), and Sjögren syndrome) and to compare that capacity with individuals 
with allergic rhinitis only and individuals with neither diagnosis. In this work, cases with 
allergic rhinitis and AID had significantly lower unstimulated IL-10 levels compared with 
controls with allergic rhinitis only, and significantly lower stimulated TGF-β levels 
compared with controls with neither diagnosis. Cases had consistently lower regulatory 
capacity compared with both control groups, as measured by an additive index using IL-
10 and TGF-β levels. In this work, the authors concluded that individuals with concomitant 
allergic rhinitis and Th1-type autoimmune disorders have a lower regulatory cytokine 
production capacity than individuals with allergic rhinitis only and those with neither 
diagnosis (Chai et al., 2005). 
In consonance with this work, a later one appeared describing that autosomal 
recessive phosphoglucomutase (PGM) 3 mutations underlie a disorder of severe atopy, 
immune deficiency, autoimmunity, intellectual disability and hypomyelination. The results 
of this study showed that marked atopy and autoimmunity were associated with increased 
Th2 and Th17 cytokine production by CD4+ T cells (Zhang et al., 2014b). In addition, a 
prospective cohort study also suggested that Th1/Th2 hypothesis was too simplistic to 
explain the interaction between atopy and systemic onset juvenile idiopathic arthritis 
(SoJIA). In this work, Zhang and collaborators described that atopy may exert an adverse 
influence on SoJIA, as patients with atopy had a more active disease at diagnosis and 
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poorer outcome. In the results, at disease onset, 61 SoJIA patients were enrolled and 
were divided into SoJIA patients with atopy or those without atopy; atopic group at 
disease onset had significantly higher numbers of affected joints, ferritin levels and IgE 
serum levels than the non-atopic group; and, during the 2 years of follow-up time, the 
number of infections and the number of flares were significantly higher in the SoJIA with 
atopy group (Zhang et al., 2014a). 
Jung and collaborators performed a study with herpes virus entry mediator 
(HVEM), a newly discovered member of the tumour necrosis factor receptor (TNFR) 
superfamily that has a role in herpes simplex virus entry, in T cell activation and in tumour 
immunity. They generated monoclonal antibodies against HVEM and detected soluble 
HVEM in the sera of patients with various autoimmune diseases. HVEM was constitutively 
expressed on CD4+ and CD8+ T cells, CD19+ B cells, CD14+ monocytes, neutrophils and 
dendritic cells. In this work, the authors show that soluble HVEM levels were elevated in 
sera of patients with allergic asthma, atopic dermatitis and rheumatoid arthritis suggesting 
that the detection of soluble HVEMs might have diagnostic and prognostic value in certain 
immunological disorders (Jung et al., 2003). 
Also, in the previously referred study of Pacheco-Gonzalez, the authors showed 
that the genetic variants of FOXP3 that are more frequent in children who share allergic 
and AID, may alter the expression levels of FOXP3 modifying its function. In fact, FOXP3 
gene is expressed mainly in a subgroup of CD4+ cells, called regulatory cells (Treg) that 
represent 5-10% of CD4+ T cells (Sakaguchi, 2005) and regulate the innate and adaptive 
immunity, thus contributing to the maintenance of immune tolerance (Rudensky, 2011; 
Sakaguchi, 2005). When their function is affected, autoimmune and allergic diseases can 
appear (Pacheco-Gonzalez et al., 2016). 
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CONCLUSIONS 
 
This review listed systematically the studies performed in the last fifteen years that 
establish an epidemiological, etiological or pathophysiological relationship between 
autoimmune and allergic diseases. In what concerns the epidemiology of both diseases, 
several works were published in the last years. Thus, although some authors reported 
results to the contrary, most studies point to an increase of co-prevalence of autoimmune 
and allergic diseases suggesting a relationship between them. Despite the increasing 
number of studies demonstrating this, there is some lack of information regarding the 
temporal relationship between the onset of one or the other disease. In fact, it would be 
interesting to know if both diseases co-exist or if, on the other hand, the existence of 
childhood allergies leads to the development of autoimmune diseases in adults (and vice 
versa).  
Contrary to the results obtained regarding epidemiological data, in relation to the 
etiology and pathophysiology of the diseases, little has been added in the last fifteen 
years. In fact, only some authors described an overlap of genetic characteristics in 
autoimmune and allergic diseases. Although this information is important, it would be 
interesting to clarify common genetic mechanisms and relate them to the pathophysiology 
of the diseases. Commonalities in the genetic characteristics of both autoimmune and 
allergic diseases could provide a key to understand the complex relationship between 
them by pinpointing possible common pathophysiological mechanisms.  
Based on the findings of this review, given the increasing evidence of a 
relationship between autoimmune and allergic diseases and the lack of knowledge in what 
concerns the overlap of their pathophysiologic mechanisms, future research should focus 
on identifying the basic mechanism of this relationship.  
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